SEC Form 4 · accession 0001209191-15-003186
SALIX PHARMACEUTICALS LTD · SLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Forbes
Officer — EVP Research&Devel & CDO
Period of report
Jan 2, 2015
Accepted (ET)
Jan 8, 2015 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001009356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2015 | F | 10,997 | $114.94 | D | 114,594 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.